Multicenter prospective phase II study of sunitinib in non-clear cell type renal cell carcinoma

被引：0
|
作者：
Lee, J.
Ahn, J.
Lim, H.
Lee, S.
Kim, T.
Lee, D.
Cho, Y. M.
Hong, J.
Kim, C.
Ahn, H.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
325
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II, Multicenter, Uncontrolled Trial of Single-agent Capecitabine in Patients With Non-clear Cell Metastatic Renal Cell Carcinoma
    Tsimafeyeu, Ilya
    Demidov, Lev
    Kharkevich, Galina
    Petenko, Natalia
    Galchenko, Vladimir
    Sinelnikov, Igor
    Naidzionak, Uladzislau
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 251 - 254
  • [22] The role of immunotherapy in non-clear cell renal cell carcinoma
    Climent, Carla
    Soriano, Sandra
    Bonfill, Teresa
    Lopez, Natalia
    Rodriguez, Marta
    Sierra, Marina
    Andreu, Pablo
    Fragio, Monica
    Busquets, Mireia
    Carrasco, Alicia
    Cano, Ona
    Segui, Miguel-Angel
    Gallardo, Enrique
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
    Xu K.Y.
    Wu S.
    Biomarker Research, 3 (1)
  • [24] Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
    Costello, Brian Addis
    Thai Huu Ho
    Tan, Winston
    Leibovich, Bradley C.
    Castle, Erik P.
    Parker, Alexander S.
    Dronca, Roxana Stefania
    Qin, Rui
    Kohll, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Pazopanib for treatment of metastatic renal cell carcinoma with non-clear cell histology: Single-arm, open label, multicenter, phase II study.
    Jung, Ki Sun
    Cho, Jinhyun
    Yoo, Kwai Han
    Park, Se Hoon
    Lee, Jae-Lyun
    Lee, Se-Hoon
    Lim, Jae Yun
    Kang, Jung Hun
    Lee, Suee
    Rha, Sun Young
    Lee, Kyung Hee
    Kim, Ho Young
    Lim, Ho Yeong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [26] Efficacy of sunitinib and sorafenib in non-clear cell renal cell carcinoma: Results from expanded access studies
    Strumberg, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) : 3469 - 3471
  • [27] Targeted therapies for non-clear renal cell carcinoma
    Eric A. Singer
    Gennady Bratslavsky
    W. Marston Linehan
    Ramaprasad Srinivasan
    Targeted Oncology, 2010, 5 : 119 - 129
  • [28] Targeted therapies for non-clear renal cell carcinoma
    Singer, Eric A.
    Bratslavsky, Gennady
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    TARGETED ONCOLOGY, 2010, 5 (02) : 119 - 129
  • [29] Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
    Heng, Daniel Y. C.
    Bukowski, Ronald M.
    ONCOLOGY REVIEWS, 2007, 1 (03) : 170 - 176
  • [30] Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial
    Bilen, Mehmet Asim
    Zurita, Amado J.
    Ilias-Khan, Nasreen A.
    Chen, Hsiang-Chun
    Wang, Xuemei
    Kearney, Alper Y.
    Hodges, Sherie
    Jonasch, Eric
    Huang, Shixia
    Khakoo, Aarif Yusuf
    Tannir, Nizar M.
    ONCOLOGIST, 2015, 20 (10): : 1140 - 1148
12345